Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuroimmune Mechanisms in Obesity
NCT05553405Phase 1Withdrawn
- Sponsor
- Yale University
- Start
- Jan 2024
- Primary completion
- Jan 2033
- Countries
- 1
01
Overview
Phase 1, open-label trial (3 arms), sponsored by Yale University. Primary endpoints: Baseline [11C]PBR28 VT values, Post-Intralipid [11C]PBR28 VT values and 4 more. Planned start Jan 2024; status: withdrawn.
Beyond the preview
Go deeper on NCT05553405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05553405.